Cardiome Pharma Corp. (USA) (NASDAQ:CRME)

CAPS Rating: 3 out of 5

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

Recs

0
Player Avatar douchrti (59.18) Submitted: 7/31/2009 11:34:30 AM : Outperform Start Price: $4.07 CRME Score: -123.44

Biotech and Biomedical industries are the new future for jobs and research.

Featured Broker Partners


Advertisement